<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The recent recognition of genetic defects in telomeres and telomere repair in multiple human diseases has practical implications for hematologists and oncologists and their patients; consequences for future clinical research in hematology and other subspecialties; and even importance in the interpretation of animal experiments involving cell propagation </plain></SENT>
<SENT sid="1" pm="."><plain>Telomere diseases include constitutional marrow failure as <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita, some apparently acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>; <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo>; and hepatic nodular regenerative <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> and <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Accelerated telomere attrition is a likely pathophysiology of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> arising from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Telomerase can be modulated by sex hormones, which may explain the activity of <z:chebi fb="5" ids="50113">androgens</z:chebi> in marrow failure </plain></SENT>
<SENT sid="4" pm="."><plain>Measurement of telomere length of peripheral blood leukocytes is a simple screening clinical assay </plain></SENT>
<SENT sid="5" pm="."><plain>Detection of a mutation in a patient has implications for therapy, prognosis, monitoring, and genetic counseling </plain></SENT>
<SENT sid="6" pm="."><plain>For research in hematology and <z:hpo ids='HP_0002664'>oncology</z:hpo>, telomere biology could be assessed as a risk for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary malignancies</z:e> and in <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, for progression in a variety of <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">blood cancers</z:e>, and as potentially modifiable by hormone replacement strategies </plain></SENT>
</text></document>